With a growing global network, Ardena operates five strategically located facilities across Europe, along with commercial offices in key global regions. Our state-of-the-art facilities are engineered to support early-phase development for oral drugs, injectables, and nanomedicines
Kleimoer 4, Ghent, Belgium
Kloosterstraat 9, 5349 AB Oss, Netherlands
Tallvägen 6, 151 38 Södertälje, Sweden
Calle Noáin, 1, Noáin, Spain
W.A. Scholtenstraat 7, 9403 AJ Assen, Netherlands
Technology Square, Cambridge, MA, USA
Alderley Park, Congleton Road, Nether Alderley, Macclesfield SK10 4TG, UK
53 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, South Korea
Our headquarters in Ghent is home to specialist expertise and tailored CMC regulatory services engineered to support you from pre-clinical to clinical manufacturing.
At this site our formulation and manufacturing capabilities are focused in injectable drugs, as well as oral drugs, especially those with low solubility challenges.
Our site in Oss is situated on Pivot Park, a reputed Life Sciences campus with a special focus on pharmaceutical innovation in the Netherlands. At Ardena Oss, we focus on drug substance, solid state, and nanomedicines services, including highly potent compounds.
Ardena Södertälje AB has brought dozens of active pharmaceutical ingredients (API) from early lead molecules to clinical studies.
Focusing on small-molecule oral solid drugs, our Pamplona site specializes in highly potent compounds and differentiating technologies including spray drying, from development to clinical manufacturing for early and late phases, as well as commercial manufacturing of niche drugs.
Assen is a highly specialized and innovative facility that offers a full range of bioanalytical services from drug discovery research up to phase IV clinical studies.
Situated in one of the world’s premier biotech hubs, Ardena’s commercial office in Boston plays a pivotal role in engaging with clients across the North American market. This office is dedicated to fostering partnerships and providing localized support, ensuring that companies in the region have direct access to Ardena’s comprehensive range of services and expertise in early-phase drug development. With its strategic location in Boston’s vibrant life sciences community, our office is well-positioned to support innovation and collaboration in the pharmaceutical and biotech industries.
Located in the heart of one of the UK’s most renowned life sciences hubs, our commercial office at Alderley Park positions Ardena at the forefront of the British pharmaceutical and biotech industries. This office focuses on building relationships with regional partners and providing tailored consultations on Ardena’s comprehensive drug development expertise, ensuring clients in the UK benefit from local access to our services.
Ardena’s commercial office in Cheongju is a key point of contact for clients across the Asia-Pacific region. Situated within South Korea’s growing biotech landscape, this office is dedicated to supporting collaborations and providing local access to our global CDMO and bioanalytical CRO capabilities, ensuring that companies in the region benefit from Ardena’s specialized expertise and services.
Using the right standards at the right development phase, our comprehensive program management services streamline your small molecule drug development.
Helping you turn your compounds that show promise into GMP-grade drug substances.
We advance your clinical candidates through the pipeline quickly and safely with specialist drug product services.
Our bioanalytical platform supports your preclinical and clinical stages with expert testing services.
Our comprehensive CMC regulatory services streamline preparation and submission of your registration file.
Using the right standards at the right development phase, our comprehensive program management services streamline your large molecule drug development.
We advance your large molecule candidates through the pipeline quickly and safely with specialist drug product services.
Our bioanalytical platform supports your large molecule drugs through preclinical and clinical stages with expert testing services.
Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your large molecule drug.
Using the right standards at the right development phase, our comprehensive program management services streamline your nanomedicine drug development.
We turn your nanomedicine candidates into suitable drugs with specialist development and manufacturing services.
Our bioanalytical platform supports your preclinical and clinical stages with expert testing services.
Our comprehensive CMC regulatory services streamline the preparation and submission of the regulatory files for your nanomedicines.
We have a deep understanding and exceptional experience which we leverage to guide our approach and deliver the best possible outcomes for our partners.
Get in touch to see how we can craft your path to the clinic with dedicated capabilities.